Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer
about
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsEmerging therapeutic targets in esophageal adenocarcinomaPI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical applicationEsophageal cancer: Recent advances in screening, targeted therapy, and managementChemotherapy targeting cancer stem cellsDissecting the role of AMP-activated protein kinase in human diseases.Ribosomal DNA copy number loss and sequence variation in cancerRETRACTED: Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis.Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment StrategiesExpression of esophageal carcinoma related gene 4 (ECRG4) and its clinical significance in prognosis of esophageal carcinoma.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter StudyMetformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.Metformin targets multiple signaling pathways in cancer.HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotypeThe double-edged sword of AMPK signaling in cancer and its therapeutic implications.Combinational strategies of metformin and chemotherapy in cancers.The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway.Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine.Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein ActivationMetformin and blood cancersMicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)Metformin inhibits ovarian cancer growth and migration in vitro and in vivo by enhancing cisplatin cytotoxicity
P2860
Q26750845-F0623B9F-0AB5-416B-9B4A-B7B660588F92Q26751209-66BD45DA-6C3B-4FC2-BDA1-1A0EFBAFCC2FQ26801538-DEBFDA05-A17C-4D2D-8147-1BA52615B2FEQ26865552-0B8AAE14-26B3-4F49-B3F8-EA16CDB82653Q28085377-43297845-07FE-4691-9A0D-4C681AD1A7D5Q33682914-B4361903-395F-41C3-9DDE-8F78761B6822Q33825098-FBA6BDB9-61AD-4F74-8065-AB8101F09288Q35758949-A6B436BE-D738-4483-947C-EDCDABA88E5FQ35982489-E3FF4FF0-BEFC-480E-9E1B-42561FEB529DQ36464618-E7840E99-3EAF-469F-9CB9-AF46BDDC0834Q36561571-D2AC3FAE-FCA3-4387-A4B1-6A5A4529FB35Q37193603-496B86D5-DFC1-4141-976B-513578BAAB25Q37317523-789BDAEF-6933-4D67-BF97-BE8E9CCF52F1Q37609790-93FE3D3C-9E8D-4374-9842-14FBFDD2F19DQ37636751-5D782F80-8B4A-4266-A9FC-B160A7862ADAQ37697040-2C44A8D0-F561-43D6-B571-56D74C80DC64Q37706921-7B3EA88F-CC7D-4735-8B6B-E5579323F0A7Q38313164-68C3E0B7-E884-4062-A2E7-2BA569556A0FQ38818730-75C28912-DA28-45CD-BAAE-142A028D186AQ38903548-E0A759EA-1A94-4DDC-BB8B-716F39084686Q41036251-0361870F-7492-46BB-B082-81AFC38792EAQ41091261-976E6D60-0D9D-4399-8602-14F2AA43E948Q42131289-2A6E7497-75AD-412F-B7B0-43BA194C6ACBQ49658205-6244B1A3-757E-4B0E-B0A5-A969079002C7Q50001260-E8CD2333-579A-400F-9BC0-B8AAB418EB7AQ52715285-5FF994AF-7AE9-4E49-B6F4-DA3F8CD0E1C7Q57109201-F636CB59-A723-4234-A310-7987B836F4F5Q58699189-6DAC24CF-6D45-44FC-8D27-ED13672B9113Q58700608-C6A8E739-63E2-4DD3-8269-F6868EABEECEQ58733981-88274614-B64F-4D89-9671-52C95618B580
P2860
Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metformin sensitizes chemother ...... R pathway in esophageal cancer
@ast
Metformin sensitizes chemother ...... R pathway in esophageal cancer
@en
type
label
Metformin sensitizes chemother ...... R pathway in esophageal cancer
@ast
Metformin sensitizes chemother ...... R pathway in esophageal cancer
@en
prefLabel
Metformin sensitizes chemother ...... R pathway in esophageal cancer
@ast
Metformin sensitizes chemother ...... R pathway in esophageal cancer
@en
P2093
P2860
P356
P1476
Metformin sensitizes chemother ...... R pathway in esophageal cancer
@en
P2093
Ailing W Scott
Heath D Skinner
John Stroehlein
Qiongrong Chen
Randy L Johnson
Shumei Song
Soichiro Honjo
P2860
P304
P356
10.3892/IJO.2014.2450
P50
P577
2014-05-21T00:00:00Z